Oncogenic Signaling Adaptor Proteins

Leo Y Luo1, William C Hahn2

  • 1Health Sciences and Technology Program, Harvard Medical School, Boston, MA 02115, USA.

Insights

Adaptor proteins CRKL, GAB2, and FRS2 are newly identified oncogenes. Amplification of these genes drives lung and ovarian cancers, highlighting them as potential therapeutic targets.

Area of Science:

  • Molecular biology
  • Cancer genetics
  • Signal transduction

Background:

  • Receptor tyrosine kinases (RTKs) activate critical cell signaling pathways.
  • Adaptor proteins scaffold key signaling events downstream of RTKs.
  • Recent genomic studies reveal adaptor proteins as novel oncogenes.

Purpose of the Study:

  • To review the discovery, structure, function, and therapeutic potential of three adaptor oncogenes: CRKL, GAB2, and FRS2.
  • To highlight the role of these adaptor proteins in cancer development.

Main Methods:

  • Integration of structural and functional genomic approaches.
  • Analysis of gene amplification in cancer cell lines.
  • In vitro and in vivo transformation assays.

Main Results:

  • CRKL, GAB2, and FRS2 are recurrently amplified in lung adenocarcinoma and ovarian cancer.
  • These amplified genes are essential for cancer cell line survival.
  • Overexpression transforms immortalized human cell lines.

Conclusions:

  • Adaptor proteins represent a distinct class of oncogenes.
  • These adaptor oncogenes are crucial drivers of specific cancers.
  • CRKL, GAB2, and FRS2 are promising therapeutic targets for cancer treatment.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.2K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K